Human-Led Content Creation Services for Biotech Companies
Content creation for biotech companies includes the research, writing and editing of the pages, articles and guides a biotech company publishes for partners, investors and researchers.
How does human-led content compare with AI-generated content for biotech companies?
Human-led content is researched, written and edited by people. This is how it differs from pages generated by AI with no writer or editor involved.
| Human-led content from Emulent | AI-generated content with no editor | |
|---|---|---|
| Where the facts come from | Interviews with your team, your own records and named sources | Whatever is already published online, blended together |
| Who checks it | An editor, then someone at your biotech company before it goes live | Often no one, so errors and made-up details can be published |
| How it reads | Like your biotech company, with examples partners, investors and researchers recognize | Like every other site in the industry |
| How search engines treat it | Original detail and first-hand experience are what Google’s guidance on helpful content asks for | Google’s spam policies target pages mass-produced with little effort or originality |
Which biotech company content problems does Emulent solve?
The content problems biotech companies bring us most often:
What do content creation services for biotech companies include?
Every step is done by a person, from the first interview to the final edit.
Topic research
We find the questions partners, investors and researchers ask, in search data and in your inbox, and pick the topics most likely to lead to partnering and investor inquiries.
Interviews with your team
A writer interviews the people who do the work. Their answers, examples and numbers are what make the content yours.
Writing
Platform and pipeline pages, science explainers, leadership articles and investor and partner materials. Each piece is optimized for SEO and AI search.
Editing and fact-checking
An editor reviews every piece for accuracy, clarity and tone. Facts, figures and quotes are checked against their source.
Your review and publishing
You approve each piece before it goes live. We format it, add images and publish it to your site.
Updates and reporting
Older pieces are reviewed and refreshed on a schedule, and a monthly report shows traffic and partnering inquiries.
How does Emulent create content for biotech companies?
Five steps, each one handled by a person.
Interview
A writer talks with your team about the work, the customers and the questions partners, investors and researchers ask.
Plan
You get a content calendar with topics, formats and dates. You approve it before writing starts.
Write
The writer drafts each piece from the interview, your records and checked sources, and optimizes it for SEO and AI search: clear headings, direct answers and the terms your customers search for.
Edit and approve
An editor reviews the draft, then it goes to you. Nothing is published without your approval.
Publish and measure
We publish the piece, track traffic and partnering inquiries, and use the results to plan the next month.
What do biotech companies ask about content creation?
Is the content written by people or by AI?
By people. A writer researches and writes every piece, and an editor signs off on it. Where we use software, it is for keyword data, interview transcripts and grammar checks.
Who can explain our science in plain language?
A science writer who interviews your researchers. The draft goes back to them until the explanation is both clear and correct.
What does content creation cost for biotech companies?
Content is priced per piece or as a flat monthly plan, based on the number and length of pieces. You see the price before any work starts.
How long does one piece take?
Most pieces take two to three weeks from the interview to publishing, including your review.
Is your biotech company’s content written by people who know the work?
Human-led content for biotech companies starts with a conversation with the people who do the job.
Let’s Talk